Connect Biopharma Holdings Ltd

Connect Biopharma Holdings Ltd.

Biotechnology • Healthcare • San Diego, CA, United States • CNTB (NGM)

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of inflammatory diseases in the United States. The company's lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is in Phase 3 studies for the treatment of inflammatory diseases such as atopic dermatitis and asthma. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California.

858 727 1040 3580 CARMEL MOUNTAIN ROAD, San Diego, CA 92130, United States

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Discovering Connect Biopharma Holdings And 2 Other Promising Penny Stocks - Yahoo Finance
Yahoo Finance • Dec 23
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
MarketBeat • Dec 26
Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Lansing State Journal
Lansing State Journal • Dec 26
Connect Biopharma Completes Termination of its American - GlobeNewswire
GlobeNewswire • Sep 3
Biotech Connect Biopharma Completes Strategic Shift to Direct Nasdaq Listing for U.S. Growth - Stock Titan
Stock Titan • Sep 3

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Connect Biopharma Holdings Ltd had layoffs?
No layoff events have been recorded for Connect Biopharma Holdings Ltd in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Connect Biopharma Holdings Ltd have?
Connect Biopharma Holdings Ltd has approximately 62 employees.
What industry is Connect Biopharma Holdings Ltd in?
Connect Biopharma Holdings Ltd operates in the Biotechnology industry, within the Healthcare sector.
Is Connect Biopharma Holdings Ltd a publicly traded company?
Yes, Connect Biopharma Holdings Ltd is publicly traded under the ticker symbol CNTB on the NGM. The company has a market capitalization of approximately $0.15 billion.
Where is Connect Biopharma Holdings Ltd headquartered?
Connect Biopharma Holdings Ltd is headquartered in San Diego, CA, United States at 3580 CARMEL MOUNTAIN ROAD, San Diego, CA 92130, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.